BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 103 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,760 | -64.3% | 1,015 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $18,940 | -32.4% | 1,015 | -22.2% | 0.00% | 0.0% |
| Q4 2022 | $28,031 | +81.7% | 1,305 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $15,425 | -10.5% | 1,305 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,226 | -36.9% | 1,305 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $27,288 | -72.5% | 1,305 | -73.3% | 0.00% | 0.0% |
| Q4 2021 | $99,251 | -33.0% | 4,882 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $148,169 | +28.3% | 4,882 | +22.9% | 0.00% | 0.0% |
| Q2 2021 | $115,455 | -21.3% | 3,973 | +16.8% | 0.00% | 0.0% |
| Q1 2021 | $146,787 | -6.6% | 3,401 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $157,126 | +6.5% | 3,401 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $147,467 | -18.2% | 3,401 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $180,287 | – | 3,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 15,040 | $177,772,000 | 0.69% |
| AlphaCentric Advisors LLC | 50,000 | $591,000 | 0.61% |
| Artemis Investment Management LLP | 1,374,496 | $16,260,000 | 0.18% |
| Knoll Capital Management, LLC | 20,000 | $236,000 | 0.14% |
| Game Plan Financial Advisors, LLC | 11,280 | $133,000 | 0.11% |
| Virtus ETF Advisers LLC | 11,365 | $134,000 | 0.05% |
| AllSquare Wealth Management LLC | 5,527 | $65,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 34,231 | $405,000 | 0.03% |
| Aquatic Capital Management LLC | 10,000 | $118,000 | 0.01% |
| Jump Financial, LLC | 26,000 | $307,000 | 0.01% |